世界经济论坛-从政策到实践_商业生物经济的可行建议（英）-2025.6_39页_4mb

Summary of "From Policy to Practice: Actionable Recommendations for a Commercial Bioeconomy"

Introduction

The bioeconomy offers significant potential for economic growth, sustainability, and resilience by leveraging innovations in life sciences, biotechnology, and engineering biology. Current national strategies aim to accelerate its development, but translating these into market-ready solutions remains challenging due to limited mainstream adoption. The report emphasizes the need for a market-pull approach to ensure bio-innovation is commercially viable, environmentally sustainable, and strategically advantageous amid geopolitical uncertainty and economic volatility.

Key Challenges

Despite rapid technological advancements, bio-innovation faces barriers in scaling from research to commercial applications:

• Regulatory Hurdles: Unclear or outdated regulations delay approvals and limit innovation.
• Funding Gaps: The "valley of death" between lab discoveries and market entry requires more investment and tailored financing.
• Demand Shortfalls: Insufficient incentives and high costs slow consumer and corporate adoption.
• Workforce Gaps: Lack of skilled professionals and regulatory expertise hampers growth.

Actionable Recommendations

The report provides 14 targeted recommendations across four categories:

1. Regulation

• Increase access to testbeds (e.g., Test Farms) for empirical validation of innovations.
• Streamline regulatory pathways (e.g., UK's Regulatory Innovation Office) to reduce delays.
• Embed technical experts in policy-making (e.g., Japan's SciREX Program) to ensure relevance.
• Enhance transparency and stakeholder engagement through educational programs and public consultations.

2. Incentives

• Use tax credits and targeted incentives (e.g., China's tax breaks) to encourage early adoption by corporations and consumers.
• Provide consumer incentives, such as grants for bioproduct use (e.g., Canada's Greener Homes Grant), to drive market demand.
• Support beta-testing programs for large-scale integration (e.g., Zambian ethanol project) to accelerate commercial viability.

3. Financing

• Promote blended financing models combining public and private funds (e.g., Singapore's equity schemes).
• Increase early-stage funding through flexible mechanisms like ARPA-H to share risks and de-risk innovation.
• Invest in shared scaling infrastructure (e.g., India's biomanufacturing hubs) to reduce costs and support diversification.

4. Access and Education

• Fund education and reskilling programs (e.g., Brazil's vocational training) to build a skilled workforce.
• Develop innovation ecosystems and networks (e.g., South Korea's bioclusters) to foster collaboration and knowledge sharing.
• Enhance regulatory expertise through continuous training (e.g., Thailand's biosafety programs) to keep pace with technological advances.

Conclusion

Collaboration between governments, industry, and academia is essential to transform policy ambitions into commercial successes. By implementing these recommendations, stakeholders can unlock the bioeconomy's full potential, driving sustainable economic growth, supply chain resilience, and global competitiveness. Proactive, coordinated efforts will address current gaps and position the bioeconomy as a cornerstone for future prosperity.